Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health,

where we bring evidence, experience, and perspective to make sense of today's leading health challenges.

If you have questions or ideas for us, please send an email to public health question at jh.h.u.

That's public health question at jh.u.edu for future podcast episodes.

Hi listeners. It's Lindsay Smith Rogers. Today, access to in vitro fertilization, otherwise known as IVF.

Sean Tipton is the chief advocacy and policy officer of the American Society of Reproductive Medicine.

He joins Dr. Josh Sharstein to talk about the recent White House announcement on IVF

and how much of a step forward in access to care it represents.

Let's listen.

Sean Tipton, thank you so much for joining me here on Public Health on

Call. Can you tell me a little bit about the American Society for Reproductive Medicine?

Sure. So the acronym we use as ASRM was founded in 1944. We've got about 7,000 members around the world

who are not only physicians to work primarily in reproductive health, including infertility care, but actually all members of the cross-disciplinary team.

So our membership includes nurses and advanced practice nurses and genetic counselors and mental health people and practice managers and even highly unusual for a medical group.

We even have lawyers in our membership.

And what is their common goal?

Well, I mean, they are all about advancing reproductive care.

So in the broad spectrum, that's any aspect of people's reproductive lives.

You know, we talk about going contraception,

infertility, menopause, all those kind of things are the subjects of the research and care that

our members provide. Today we're going to talk about assisted fertility. Tell me about that technology

and a little bit maybe about how it's changed over the years.

...